-
Featured ArticleApril 16, 2024Incorporating diverse background genetics to better model human disease
JAX scientists are working to make it more feasible for researchers to incorporate diverse background genetics to better model human disease in mice. -
Research HighlightApril 03, 2024Making mice a more powerful research tool
A new protocol sets the stage for researchers to directly compare mouse and human cells, and readily incorporates genetic diversity into mouse-based research to more closely approximate human health conditions. -
Research HighlightMarch 26, 2024CRISPR provides potential cardiomyopathy treatment
JAX researchers have developed a potential new treatment for dilated cardiomyopathy (DCM), a sometimes fatal heart condition that affects as many as one in 200 adults worldwide. -
Featured ArticleMarch 14, 20242024 Paigen Fellowship recognizes postdoctoral talent
The Paigen Fellowship supports postdoctoral associate Abdulfatai Tijjani's humanistic approach to research.
-
Research HighlightApril 16, 2024Developing immune therapy without immune toxicity
A team led by David Serreze presents a mouse model for studying severe immune checkpoint inhibition-based damage to heart and skeletal muscle, providing an important resource for maximizing the benefits and minimizing the side effects of vital immunotherapies. -
Featured ArticleMarch 26, 2024Working to characterize the function of protein-coding genes in the mouse
Using KOMP2, JAX researchers have now generated and characterized more than 2,000 knockout mice, gaining important insights into mammalian genetics and potential health impacts. -
Press ReleaseMarch 21, 2024Aubrey Watkins III appointed VP of Corporate Development
Industry leader and innovator will help advance JAX’s mission. -
Featured ArticleMarch 12, 20242024 JAX Scholars announced
JAX is proud to announce Takeshi Iwasaki, M.D., Ph.D., and Morgan Severn, Ph.D., as the 2024 JAX Scholars.